Ameritas Investment Partners, Inc. Gritstone Bio, Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $12,031 - $21,961	7,248 New	7,248 $14,000
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $5,844 - $14,330	-3,302 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.76 - $13.71 $6,622 - $10,364	756 Added 29.69%	3,302 $42,000
Q1 2021 May 14, 2021	BUY	$4.07 - $27.11 $1,505 - $10,030	370 Added 17.0%	2,546 $24,000
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $14,775 - $25,214	1,606 Added 281.75%	2,176 $24,000
Q4 2018 Feb 12, 2019	BUY	$11.61 - $31.1 $6,617 - $17,727	570 New	570 $9,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.